ARTICLE | Company News
4AZA Bioscience NV, Gilead deal
December 5, 2005 8:00 AM UTC
4AZA granted GILD an exclusive worldwide license to research, develop and commercialize undisclosed compounds to prevent and treat HCV. GILD will make an equity investment in 4AZA and pay the Belgian ...